For treatment of hyperuricemia, reduces elevated plasma uric acid levels (from chemotherapy).
Examples of Clinical Use:
Drugs used to treat lympohoid leukemia, non-Hodgkin's lymphoma and acute myelogenous leukemia often lead to the accumulation of toxic plasma levels of purine metabolites (i.e. uric acid). The injection of the product reduces levels of uric acid and mitigates the toxic effects of chemotherapy induced tumor lysis.
Mechanism of action:
Rasburicase catalyzes enzymatic oxidation of uric acid into an inactive and soluble metabolite (allantoin).
For research use only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products
without prior written approval from Creative BioMart.
For more information on how our products could help advance your project, please contact us.